|
Exports of drugs and pharmaceuticals from the country registered a 2.37 per cent growth in the first month of the current fiscal year, while imports reported a significant jump of 9.53 per cent compared to the same month of previous year.
The exports for the month of April, 2025 stood at $2.486 billion as against $2.228 billion reported during the corresponding month of previous fiscal year, according to data from the ministry of commerce and industry.
The growth has declined, after exports during the month of March, 2025 registering a growth of 31.21 per cent, highest monthly export growth during FY25.
In Rupee terms, the exports growth was 5.02 per cent to Rs. 21,270.5 crore during April, 2025, as compared to Rs. 20,254.22 crore during the same month of previous year.
Imports of medicinal and pharmaceutical products during April reported a growth of 9.53 per cent to $749.04 million, as against $683.88 million imports during the same month a year ago.
Imports during April, 2024 was a growth of 18.4 per cent as against $577.39 million registered in April, 2023, according to data.
In Rupee terms, the imports reported growth of 12.36 per cent to Rs. 6,408.84 crore in April, this year, as against Rs. 5,703.99 crore during the same month last year.
It may be noted that the exports has registered a 9.39 per cent growth during the financial year 2024-25. Exports during the 12 months ended March, 2025 was at $30.47 billion, as compared to $27.85 billion reported in the previous year.
The exports reported a 9.67 per cent growth during the financial year 2023-24, at $27.85 billion as compared to $25.39 billion registered for the corresponding 12 months of financial year 2022-23.
The growth in FY24 and FY25 is higher as compared to a meagre 3.25 per cent growth reported during the fiscal year 2022-23. Exports reported in 2022-23 was $25.39 billion as compared to $24.59 billion in the fiscal year 2021-22.
During the month of March, 2025, exports of drugs and pharmaceuticals has grown to $3.68 billion, as compared to $2.80 billion during the same period of previous year. It may be noted that for the month of March, 2024, the Indian pharma firms registered exports of $2.80 billion as compared to $2.49 billion reported in the same month of last year, registering a growth of 12.73 per cent.
The imports of medicinal and pharmaceutical products, during the fiscal 2024-25 grew a significant 8.42 per cent as compared to the meagre 2.02 per cent growth reported in 2023-24.
Imports during the fiscal year 2024-25 stood at $8.94 billion as compared to $8.24 billion during the same period of previous fiscal year of 2023-24. Imports was $8.10 billion in the fiscal year 2022-23.
The ministry of health and family welfare has earlier said that India's drug and pharmaceutical products exports grew by 125 per cent from Rs. 90,415 crore in 2013-14 to Rs. 2,04,110 crore in 2022-23.
|